Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100PNC2
Period2021-01-01 → 2021-12-31
Filed2022-11-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amends S100NSY7. Amended by S100PNM1 (2022-11-17).

Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥314m2020-01-01 → 2020-12-31StandaloneNet sales
Revenue¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥169m2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Revenue¥229m2017-01-01 → 2017-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOperating income
Operating income−¥1.7bn2020-01-01 → 2020-12-31StandaloneOperating income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2020-01-01 → 2020-12-31StandaloneOrdinary income
Ordinary income−¥539m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.1bn2017-01-01 → 2017-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.6bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Profit before tax−¥2.1bn2020-01-01 → 2020-12-31StandaloneIncome before income taxes
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥2.1bn2020-01-01 → 2020-12-31StandaloneProfit loss
Net income−¥912m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2017-01-01 → 2017-12-31dStandaloneNet income loss (5-year summary)
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥2.8bnat 2020-12-31StandaloneAssets
Total assets¥4.4bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.4bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.5bnat 2017-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Total liabilities¥793mat 2020-12-31StandaloneLiabilities
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.0bnat 2020-12-31StandaloneNet assets
Net assets / equity¥3.5bnat 2019-12-31dStandaloneNet assets
Net assets / equity¥2.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.9bnat 2017-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
Cash and deposits¥2.1bnat 2020-12-31StandaloneCash and deposits
Cash & equivalents¥3.2bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.1bnat 2019-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.9bnat 2017-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥238m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥942,0002021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥38m2020-01-01 → 2020-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥4m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥342m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥132m2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥242m2020-01-01 → 2020-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2017-01-01 → 2017-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-145.582020-01-01 → 2020-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-65.552019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-104.552018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-106.232017-01-01 → 2017-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥206.86at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥136.43at 2020-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥240.71at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥216.61at 2018-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥263.54at 2017-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.4%at 2020-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.9%at 2017-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued14,641,900at 2020-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued14,331,300at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued13,346,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,086,000at 2017-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees33at 2021-12-31StandaloneNumber of employees
Employees32at 2020-12-31StandaloneNumber of employees
Employees27at 2019-12-31dStandaloneNumber of employees
Employees30at 2018-12-31dStandaloneNumber of employees
Employees29at 2017-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 864
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)EY新日本有限責任監査法人
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)大　　録　　宏　　行
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)三　　島　　　　　浩
Key audit matters non consolidated (text)FilingDateInstantText · Plus
Overview kam non consolidated (text)FilingDateInstantText · Plus
Short description kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)非上場株式の関係会社株式の評価
Description including reason kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Reference kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)注記事項「（損益計算書関係）※５関係会社株式評価損」及び注記事項「（有価証券関係）４．減損処理を行った有価証券」
Auditors response kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Short description kam non consolidatedFilingDateInstant_Row2Member
Original text (Japanese)米国の委託製造開発先に対する偶発債務
Description including reason kam non consolidated (text)FilingDateInstant_Row2MemberText · Plus
Reference kam non consolidatedFilingDateInstant_Row2Member
Original text (Japanese)注記事項「（貸借対照表関係）の偶発債務」及び注記事項「（重要な会計上の見積り）」
Auditors response kam non consolidated (text)FilingDateInstant_Row2MemberText · Plus
Number of submissionFilingDateInstant2
Net sales (5-year summary)Prior4YearDuration_NonConsolidatedMember229139000JPY
Net sales (5-year summary)Prior3YearDuration_NonConsolidatedMember168549000JPY
Net sales (5-year summary)Prior2YearDuration_NonConsolidatedMember1303844000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember314179000JPY
Net sales (5-year summary)CurrentYearDuration_NonConsolidatedMember642494000JPY
Ordinary income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-1087185000JPY
Ordinary income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-1230105000JPY
Ordinary income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-539177000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-1723537000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember-1500888000JPY
Net income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember-1090703000JPY
Net income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember-1233846000JPY
Net income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember-912346000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-2095087000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember-1615439000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior4YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior3YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior2YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior4YearInstant_NonConsolidatedMember5802444000JPY
Capital stock (5-year summary)Prior3YearInstant_NonConsolidatedMember6402658000JPY
Capital stock (5-year summary)Prior2YearInstant_NonConsolidatedMember7121273000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember7436537000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember9039516000JPY
Total number of issued shares (5-year summary)Prior4YearInstant_NonConsolidatedMember11086000
Total number of issued shares (5-year summary)Prior3YearInstant_NonConsolidatedMember13346000
Total number of issued shares (5-year summary)Prior2YearInstant_NonConsolidatedMember14331300
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember14641900
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember17405200
Net assets (5-year summary)Prior4YearInstant_NonConsolidatedMember2931893000JPY
Net assets (5-year summary)Prior3YearInstant_NonConsolidatedMember2901153000JPY
Net assets (5-year summary)Prior2YearInstant_NonConsolidatedMember3454048000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2003325000JPY
Net assets (5-year summary)CurrentYearInstant_NonConsolidatedMember3593992000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2020-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2019-12-31pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2020-01-01/2020-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2020-01-01/2020-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · total assetsnon_consolidated 2020-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass